image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
a6e974449e1e18e950fba948935454a249bf1389bdf30a8ace63d7373f6a7fac.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Odds ratio (95% CI), <i>P </i>Value</td></tr><tr><td>Before accounting for confounding by indication<sup>a</sup></td><td>After accounting for confounding by indication</td></tr><tr><td>Methicillin-sensitive <i>S. aureus</i> carrier</td><td>0.5 (0.3, 1.0), 0.03</td... |
cae44f224f9ff5ab1cfe1e626a1476c2505a64dad4c8a2c6244f67a8c88884b0.png | complex | <table><tr><td> </td><td>Everolimus 1.5 mg (<i>n </i>= 61)</td><td>MMF 2 g (<i>n </i>= 61)</td></tr><tr><td colspan="3">Recipient characteristics</td></tr><tr><td>Age (years)</td><td> </td><td> </td></tr><tr><td> Mean ± standard deviation</td><td>42.5 ± 14.13</td><td>38.6 ± 11.36</td></tr><tr><td> Median... |
90dc2be5ee263fc9bafb3fecebe7deb068ea7567db03d9c2512bf2c0a191f0de.png | simple | <table><tr><td>Shape</td><td>S-12</td><td>S-11</td><td>S-10</td><td>S-9</td><td>S-8</td><td>S-7</td><td>S-6</td><td>S-5</td><td>S-4</td><td>S-3</td><td>S-2</td><td>S-1</td><td>S-0</td></tr><tr><td>Asymmetry_NEF Value</td><td>0.002</td><td>0.304</td><td>1.544</td><td>2.900</td><td>3.328</td><td>3.545</td><td>5.149</td><... |
77d2d93119c615b2c7195c3aea2ab4f6500efea4f4d4be88113732d1f5ceecbb.png | simple | <table><tr><td>Core/HP</td><td>Sample Depth</td><td>PCR-Product cp77444</td><td>PCR-Product cp103595</td><td>Cloning Success cp77444</td><td>Cloning Success cp103595</td><td>No. of Retrieved Sequences cp77444</td><td>Detected Variants cp77444</td><td>No. of Retrieved Sequences cp103595</td><td>Detected Variants cp10359... |
beb10114c0b279917f56518e1a7eea5ec07b8ab674d4da5e83ddb3917ca765f5.png | complex | <table><tr><td>Metabolite</td><td>Number of neighbors</td><td><i>P </i>value</td></tr><tr><td colspan="3">Reporter metabolites (up)</td></tr><tr><td>Glutathione [c]</td><td>10</td><td>6.0E-05</td></tr><tr><td>UDP-glucose [c]</td><td>11</td><td>3.1E-04</td></tr><tr><td>D-galactose [e]</td><td>6</td><td>2.5E-03</td></tr>... |
a513ac4b559a50c0ea038804e7acc9f76584edb5687c684c0d8d4e36109c05f9.png | complex | <table><tr><td></td><td>No nGER (<i>n</i> = 42)</td><td>nGER (<i>n</i> = 48)</td><td><i>p</i>-value</td></tr><tr><td colspan="4">Exhaled air:</td></tr><tr><td> FeNO (ppb)</td><td>15 (13–20)</td><td>17 (11–25)</td><td>0.48</td></tr><tr><td colspan="4">EBC:</td></tr><tr><td> Substance P (pg/ml)</td><td>623 (5... |
973f7b1df2a47077d9ef12603a6e08728ba7bc3310d9fe024b71b5fb14927e88.png | complex | <table><tr><td>Treatment</td><td>Belief</td><td><i>N</i></td><td>Recommendations</td><td><i>N</i></td><td>Adherence</td><td><i>N</i></td><td>Challenges to Adherence</td></tr><tr><td rowspan="3">Blood pressure</td><td rowspan="3">Believes blood pressure affects PKD</td><td rowspan="3">16</td><td rowspan="3">Prescribed b... |
1bc760c1be03314ffaa98d4d97a48bb740e6ec186b20a4e1c2deeb2c11465679.png | complex | <table><tr><td rowspan="3"></td><td colspan="4">Maternal age (years)</td></tr><tr><td colspan="2">≤15</td><td colspan="2">16–19</td></tr><tr><td>Adjusted OR (95% CI)</td><td>p-value</td><td>Adjusted OR (95% CI)</td><td>p-value</td></tr><tr><td>Antenatal medical issue<sup>a</sup></td><td></td><td></td><td></... |
00c9e071776fc00e8560fe7939fd2a7aac66723923ce98d06a20a654b4766367.png | simple | <table><tr><td>Metric</td><td>Questions</td><td>Average</td><td>Standard</td></tr><tr><td></td><td></td><td>response</td><td>deviation</td></tr><tr><td>Overall usability</td><td>1–19</td><td>6.02</td><td>1.04</td></tr><tr><td>System usefulness</td><td>1–8</td><td>6.13</td><td>0.93</td></tr><tr><td>Informati... |
490e3f2c4a0d07f280758d0de6603fdbc65657ddbdc9aab4aeeae6faf311af35.png | simple | <table><tr><td>Functional traits</td><td>Interpretation</td></tr><tr><td>Calvin–Benson cycle</td><td>CO<sub>2</sub> fixation</td></tr><tr><td>Utilization of various carbon sources</td><td>Adaptation to the diverse organic matter in sponge mesohyl</td></tr><tr><td>Anaerobic respiration</td><td>Energy supply in ano... |
6f24685b70e1c8f1c1b57c0b4da3ad1b89399e6fcc587a166ae00d8e37dd0fca.png | simple | <table><tr><td></td><td>Controls</td><td>COPD</td><td>P value</td></tr><tr><td>Gender M:F</td><td>2:6</td><td>9:7</td><td></td></tr><tr><td>Age - median (range)</td><td>63.5 (56-78)</td><td>65.5 (49-78)</td><td>0.779</td></tr><tr><td>Smoking history (pack years)</td><td></td><td></td><td></td></tr><tr><td>Median (range... |
ad29e3a10e5d16aaf3f1cb3068bf932c29aa399d07764b98b1a8ef1ec0a07dd1.png | complex | <table><tr><td>Procedures</td><td>References</td><td>Detergents</td><td>Detergent concentrations (C)</td><td>Ultrasound treatment (S)<sup>1)</sup></td><td>Homogenization (H)<sup>2)</sup></td><td>Filtration (F)</td></tr><tr><td rowspan="2">1</td><td>S.B. Singh-Verma (1968), LR. Bakken (1985)</td><td>Sodium hexametaphosp... |
f1d5459eb6d1993d4c5a6632087d47fd067feb6b6bae975b128780aa6ff8e251.png | simple | <table><tr><td>Programme, <i>Country</i></td><td>Water Frequency <sup>1</sup></td><td>Fruit Juices Frequency <sup>2</sup></td><td>Soft Drinks Frequency <sup>2</sup></td></tr><tr><td>VIASANO, <i>Belgium</i></td><td>4 (4–5)</td><td>6 (4–6)</td><td>4 (2–5)</td></tr><tr><td>Healthy kids in Bulgaria, <i>Bu... |
65d85800cc76c27a83351796435840266390d80d36d197f1afeb00b6d7529aa4.png | simple | <table><tr><td>Authors </td><td>Results </td></tr><tr><td>Gavini <i>et al.</i> [25]</td><td>Ion-implanted instruments reached significantly higher cycle numbers before fracture compared to annealed and non-implanted files.</td></tr><tr><td>Wolle<i> et al. </i>[26]</td><td>Argon II improved the performance of S1 files m... |
d949b39e331a4b588e4710372e08a0218c128f2d906a2c6b4ca3d2fd71428a59.png | simple | <table><tr><td>Cause of corneal opacification</td><td>Eyes</td></tr><tr><td>Posttrauma</td><td>25</td></tr><tr><td>Postcorneal ulcer</td><td>20</td></tr><tr><td>Glaucoma</td><td>4</td></tr><tr><td>Unknown</td><td>4</td></tr></table> |
581bdadd47c441eff0c729e501435122e222f359774d87f3df552e6b900d50c2.png | simple | <table><tr><td>Age group (years)</td><td>Total</td><td>RVID (cm)</td><td>PADP (mm Hg)</td><td>TRVel (m/s)</td><td>PASP (mm Hg)</td><td>TVI<sub>RVOT</sub> (cm)</td><td>PVCSA (cm<sup>2</sup>)</td><td>PBF (L/min)</td><td>PVR<sub>ECHO</sub> (Woods Unit)</td></tr><tr><td>Study group</td><td></td><td></td><td></td><td></td><... |
94a3df4e7d6975c681b5803ad857439c4b580ba4a5645d2b8dd45bae5b5b1f49.png | complex | <table><tr><td colspan="3">Domains</td><td>mean (SD)</td><td>Difference</td><td><i>P</i></td></tr><tr><td rowspan="2">1.</td><td rowspan="2">Activities</td><td>before</td><td>3.52 (1.41)</td><td rowspan="2">2.84</td><td rowspan="2">< 0,001</td></tr><tr><td>after</td><td>0.68 (0.93)</td></tr><tr><td rowspan="2">2.</t... |
d7ff08570b0b7f5e4c7ecbe5e09035fc53aa5abaa5026101ce4b5db730be83d2.png | simple | <table><tr><td>GenBank accession no.</td><td>Original name</td><td>Country</td></tr><tr><td>HQ591366</td><td>PCV2 , isolate 90-08-21</td><td>Croatia, 2008</td></tr><tr><td>HQ591367</td><td>PCV2, isolate 110-08-2</td><td>Croatia, 2008</td></tr><tr><td>AY256460</td><td>PCV2, strain 375</td><td>Hungary, 2003</td></tr><tr>... |
983e0c1b99412b3bc6398a8b33e6129eb21ab4d5e22b8fdf921d962bda4e32d8.png | complex | <table><tr><td></td><td colspan="2">Total</td><td colspan="2">Men</td><td colspan="2">Women</td></tr><tr><td>Descriptor</td><td>Cases/total study group, n</td><td>ID (95% CI)<sup>c</sup></td><td>Cases/total study group, n</td><td>ID (95% CI)<sup>c</sup></td><td>Cases/total study group, n</td><td>ID (95% CI)<sup>c</sup>... |
083d380d19c7bfe563a76565a839e85de3c87cb02a2b8e0793427752396b2b60.png | simple | <table><tr><td>Variable</td><td>No. patients (n = 41)*</td><td>Median expression Survivin DeltaEx3</td><td><i>AD</i></td><td><i>p</i></td></tr><tr><td>FIGO stage</td><td></td><td></td><td></td><td></td></tr><tr><td>IB</td><td>0 (8)</td><td>0</td><td>0</td><td>0.59</td></tr><tr><td>IIB</td><td>2 (16)</td><td>0.09</td><t... |
ea147ad4858550794d934d4c132516dba8ad78822faa59752cf85f542fef5b1f.png | simple | <table><tr><td></td><td>Independent association with increasing RANKL expression (<i>P</i>value)</td><td>Independent association with increasing RANK expression (<i>P</i>value)</td></tr><tr><td>Diagnosis during pregnancy (yes vs. no)</td><td><0.001</td><td>0.67</td></tr><tr><td>Tumor size (≤2 cm vs. >2 cm)<... |
9af405af9bd6ef5cc630b8a896ecc0ce792ba1d85c482d3526a66ac5496fe690.png | simple | <table><tr><td>Variable</td><td>PHDs cohort<i>N</i> = 1,346 (%)</td><td>Comparison cohort<i>N</i> = 5,384 (%)</td><td><i>p</i>-value</td></tr><tr><td>Age, years (SD)<sup>a</sup></td><td>47.38 (14.56)</td><td>46.74 (15.77)</td><td>0.183</td></tr><tr><td> <45</td><td>820 (60.92)</td><td>3,280 (60.92)</td><td></td></tr... |
0c8be69c011b255a281806d5232d90ab2e0b874555424d12491d9a7d0621e42f.png | complex | <table><tr><td>Variable</td><td>Admission Serum Chloride (Cl<sub>0</sub>)≥110 mEq/L(<i>n</i> = 303)</td><td>Admission Serum Chloride (Cl<sub>0</sub>)101–109 mEq/L(<i>n</i> = 561)</td><td>Admission Serum Chloride (Cl<sub>0</sub>)≤100 mEq/L(<i>n</i> = 181)</td><td><i>P</i>-value</td></tr><tr><td colspan... |
881ea85790481093149031398a67d343213511701caecd6265dfcb2398709bde.png | complex | <table><tr><td colspan="2">Overall ranking scale (on a scale from 1–10)</td></tr><tr><td>Question: In the last two days of care, how well did the doctors, nurses and other professional staff...</td><td>Average</td></tr><tr><td>Provide medical care that respected his/her wishes?</td><td>8.2</td></tr><tr><td>Make s... |
6d2b4d26985de3871b8748c857572ab0247234127aac9d6d050269bc133bf460.png | complex | <table><tr><td rowspan="2"></td><td colspan="4">General CVRM networks</td><td colspan="4">Specific CVRM networks</td></tr><tr><td>Mean</td><td>SD</td><td>Min</td><td>Max</td><td>Mean</td><td>SD</td><td>Min</td><td>Max</td></tr><tr><td>Density</td><td>0.38</td><td>0.17</td><td>0.08</td><td>0.83</td><td>0.37</td><td>0.22... |
2bb1bba18fdd87f06a2e632bf9779e8f8e847750002cdd0cbe509fcc96a4eeaa.png | complex | <table><tr><td> </td><td>Healthy population</td><td colspan="2">Clinic population<sup>a</sup></td><td colspan="3">Pairwise comparisons</td></tr><tr><td> </td><td>BV = 0</td><td>BV = 0</td><td>BV = 1</td><td rowspan="2">HP vs. CPBVneg</td><td rowspan="2">HP vs. CPBVpos</td><td rowspan="2">CPBVneg vs. CPBVpos</td></tr><t... |
e753d735860ea274a057805af2fe8ba4eea16d5b5b4f4dae0c2ad114b3cef630.png | complex | <table><tr><td></td><td>P-3075</td><td>Placebo</td></tr><tr><td colspan="3">Gender, N (%)</td></tr><tr><td> Males</td><td>8 (28.6)</td><td>3 (21.4)</td></tr><tr><td> Females</td><td>20 (71.4)</td><td>11 (78.6)</td></tr><tr><td colspan="3">Age, years</td></tr><tr><td> Mean ± SD</td><td>40.3 ± 11.3</td><td>39.3... |
46875d1765592cff7d684b1b7916ea9f805e231eca3ecb869b7da67f6a3a59f3.png | simple | <table><tr><td>Partner Medicines</td><td>Below 85 %</td><td>Within 85–115 %</td><td>Above 115 %</td><td>Total <i>N</i> = 254</td></tr><tr><td>Amodiaquine<sup>a</sup>n (%)</td><td>28 (25.2)</td><td>64 (57.7)</td><td>19 (17.1)</td><td>111 (100.0)</td></tr><tr><td>Median (IQR)</td><td>80.6 (72.6–82.9)</td><td>... |
497646d9f3735a40de11732afe5b29e4d243af4dabd674860564f224e7566296.png | simple | <table><tr><td>Code</td><td>Alkali Treatment</td><td>Silane Coupling Agent</td><td>Volume Fraction of Fiber <i>V<sub>f</sub></i> (vol %)</td></tr><tr><td>PA1010</td><td>-</td><td>-</td><td>-</td></tr><tr><td>HF</td><td>-</td><td>-</td><td>20</td></tr><tr><td>HF-S1</td><td>NaOH</td><td>S1 (Aminosilane)</td><td>20</td></... |
94080a8bd73a6e8532d5158df07a04c40694b4f9663994c72e5ea54917858845.png | simple | <table><tr><td>Purification step</td><td>Total fused peptide (mg)</td><td>Total p53pAnt (mg)</td><td>Purity (%)</td><td>Yield (%)</td></tr><tr><td>Total protein extract</td><td>n.d</td><td>n.d</td><td>43*</td><td>100</td></tr><tr><td>Inclusion bodies</td><td>n.d</td><td>n.d</td><td>79*</td><td>-</td></tr><tr><td>First ... |
08f4647dc26ab4b2221745fdf58dd6d7a56102d91ae6417cd7250d175002a014.png | simple | <table><tr><td>Variables</td><td>Chlorhexidine</td><td>Placebo</td><td>Dry cord</td></tr><tr><td>Hospital data</td><td>(<i>n</i> = 86)</td><td>(<i>n</i> = 86)</td><td>(<i>n</i> = 75)</td></tr><tr><td> Age of mother (years, mean ± SD)</td><td>23.87 ± 2.54</td><td>23.77 ± 2.86</td><td>25.12 ± 3.24</td... |
0b11cda23f8cc57576aada00e9a017a77ae3101914b52d7f43d8f4ef87d51e4b.png | simple | <table><tr><td># of Subband</td><td>Freq. (Hz)</td><td># of Subband</td><td>Freq. (Hz)</td><td># of Subband</td><td>Freq. (Hz)</td><td># of Subband</td><td>Freq. (Hz)</td></tr><tr><td>1</td><td>86.7</td><td>13</td><td>886.7</td><td>25</td><td>2484.6</td><td>37</td><td>7231.5</td></tr><tr><td>2</td><td>153.3</td><td>14<... |
a61f532824b5ca3158a12619f2ca6ade040a9156e7b12c42c905a678511ed5ac.png | simple | <table><tr><td>Characteristics</td><td>Frequency n = 82</td><td>Percent (%)</td></tr><tr><td><underline>Age</underline>(years)</td><td>Mean Age =27.6, SD =4.5</td><td> </td></tr><tr><td>16–20</td><td>6</td><td>7.3</td></tr><tr><td>21–25</td><td>22</td><td>26.8</td></tr><tr><td>26–30</td><td>37</td><td... |
bd2cf2ba84d945804bb194d08f1f6be2a64f135c36b3ac2c01f8a71e3b5575b9.png | simple | <table><tr><td>miR ID</td><td>Present result</td><td>Previous report</td><td>Type of sample</td><td>Reference</td></tr><tr><td>hsa-miR-106b-5p</td><td>↑</td><td>↓</td><td>Brain</td><td>[13]</td></tr><tr><td>hsa-miR-181b-5p</td><td>↓</td><td>↓</td><td>Brain, lymphoblastoid cell line</td><td>[13,1... |
9d8efd68bdbecbb20083b6bdfa56852e472f36eadb5b9fd2c892542064cfd9a7.png | simple | <table><tr><td></td><td>Accuracy (%)</td><td>Sensitivity (%)</td><td>Specificity (%)</td><td>Auc (%)</td></tr><tr><td>FEATURE 1</td><td>95.00</td><td>87.50</td><td>96.87</td><td>—</td></tr><tr><td>FEATURE 2</td><td>87.80</td><td>100.00</td><td>84.84</td><td>—</td></tr><tr><td>FEATURE 1&2</td><td>95.00</... |
f45f3e863575a35088731fc87c4387e07165af174cb538517652b0a332e2444b.png | simple | <table><tr><td>Cell Line</td><td>Tumor Type</td><td>NOTCH1 Mutation</td><td>Effect on NOTCH1 Signaling</td><td>Reference</td></tr><tr><td>KOPT-K1</td><td>T-LL</td><td>L1600P/del(P)*</td><td>Gain</td><td> [3]</td></tr><tr><td>REC-1</td><td>MCL</td><td>del(ECN1)/del(P)*</td><td>Gain</td><td>this paper/ [7]</td></tr><tr><... |
3df5caf6457f6b6cc3971f6703a6d7277a7ed1e00a54a43cece0fc240c6dca2f.png | complex | <table><tr><td>Assessment<sup>1</sup></td><td>Telehone interview</td><td>Baseline visit</td><td>3 month visit</td><td>6 month visit</td><td>12 month visit</td><td>24 month visit</td></tr><tr><td colspan="7">AD patient</td></tr><tr><td>Inclusion criteria</td><td>X</td><td></td><td></td><td></td><td></td><td></td></tr><t... |
d92512f93873cc9a162972b752bf9c14b2c6c469c94dba7e2e73428f6e477c76.png | complex | <table><tr><td rowspan="2">Gender</td><td rowspan="2">Age</td><td rowspan="2">Age at onset</td><td colspan="3">Evidence for a diagnosis of epilepsy</td><td rowspan="2">MRI</td></tr><tr><td>EEG</td><td>Other features</td><td>Treatment response</td></tr><tr><td>M</td><td>70</td><td>66</td><td>Non-specific bilateral tempo... |
361ef57d4aa6cf245b50df05b100b87bd433a891f09f9df4dc1245f76bc64131.png | complex | <table><tr><td>level of convergence</td><td>phenotype</td><td>organism</td><td>references</td></tr><tr><td colspan="4"><i>nucleotide</i></td></tr><tr><td>coding mutations in several genes</td><td>rate of proliferation in a novel host and at higher temperature</td><td>X174 virus</td><td>[21]</td></tr><tr><td>Gly119Ser i... |
309523be6ad4869ec5ee5e0f2a7c1877961086f9dc7197562a242c7be3537d0b.png | simple | <table><tr><td>Maize gene</td><td>Intron TE insertion(s)</td><td>Maize gene length (Kb)</td><td>Sorghum ortholog gene length (Kb)</td></tr><tr><td><i>ZmTti1</i></td><td>2 Kb hobo DNA transposon</td><td>20.87</td><td>12.1</td></tr><tr><td><i>ZmTti2</i></td><td>6 Kb Gypsy LTR retrotransposon</td><td>9.1</td><td>4.2</td><... |
b7879da68c414423e75b676c09ce7719e1d3560f1d63d51c7d9491e0b018d8e5.png | simple | <table><tr><td>Paternal MHC class I Haplotype<sup>a</sup></td><td>Non-BNP calves (<i>n</i> = 21)</td><td>BNP calves (<i>n</i> = 9)</td><td><i>P</i>-value<sup>b</sup></td><td>FDR-derived significance thresholds<sup>c</sup></td></tr><tr><td>A11</td><td>3</td><td>6</td><td>0.008</td><td>0.004</td></tr><tr><td>A14</td><td>... |
6cdc6b909bcabd05a2143992fd3a18db1fd3d2b66bcc1020111cbb639204039a.png | simple | <table><tr><td>ICD-10 Code</td><td># of patients</td><td>Prescribed Antibiotic</td><td>Cases that needed antibiotic</td><td>Cases that needed + received antibiotics</td><td>Appropriate prescription rate (%)</td><td>Adequate prescription rate (%)</td></tr><tr><td>J00</td><td>581</td><td>17</td><td>14</td><td>1</td><td>8... |
0f6e945ad340f6fda1093caa48824fe33b9dead60965c2c195f3a6213c22dd0f.png | complex | <table><tr><td rowspan="3">G grade</td><td colspan="3">Number of tumor samples</td></tr><tr><td colspan="3">CD146 expression</td></tr><tr><td>Low/absent</td><td>incomplete high</td><td>complete high</td></tr><tr><td>1</td><td></td><td>3</td><td></td></tr><tr><td>2</td><td>4</td><td>3</td><td>12</td></tr><tr><td>3</td><... |
d0a4a0b014c47b4c4274eb8b15118bdc302f710e65a46c18dd67ab0a04ad3372.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Base model</td><td colspan="2">Effect modification model</td></tr><tr><td>OR</td><td>95%CI</td><td>OR</td><td>95%CI</td></tr><tr><td>SNAP participation (ref = eligible non-participants)</td><td>2.02</td><td>1.44-2.83</td><td>2.09</td><td>1.48-2.95</td></tr><tr><td>Age (ye... |
220bbf26653f7edbfa1981758f4b85aa904f47d3a1d016602b9696e94db18db0.png | complex | <table><tr><td>RADIODENCITY OF BONE GRAFTS</td><td colspan="2">At 7<sup>th </sup>day follow-up</td><td colspan="2">At 1st month follow-up</td><td colspan="2">At 6 months follow-up</td><td colspan="2">At 1 year follow-up</td></tr><tr><td></td><td>No. of pts.</td><td>%</td><td>No. of pts.</td><td>%</td><td>No. of pts.</t... |
a4db1de3ca95a778cc4b49015c455caec52d030bbf98e9cbc82dc216522fafe3.png | simple | <table><tr><td></td><td>1st visitFebruary 2012</td><td>2nd visitApril 2012</td><td>Last visit before starting dialysis June 2014</td></tr><tr><td>Weight (kg)</td><td>84,3</td><td>82,9</td><td>76</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>29</td><td>28</td><td>25</td></tr><tr><td>eGFR (mL/min/1,73 m<sup>2</sup>)</t... |
8457bff05290ef2aab7d4b2aa7f14538a88a0fc20c035fe1d93c8fc736cc18b7.png | complex | <table><tr><td>Subject number</td><td>Region of interest</td><td>H&E staining</td><td>APP staining</td></tr><tr><td rowspan="6">Sheep 01</td><td>AL</td><td>Normal</td><td>0</td></tr><tr><td>AR</td><td>Normal</td><td>1</td></tr><tr><td>BL</td><td>Normal</td><td>0</td></tr><tr><td>BR</td><td>Microglial activation</td... |
0f5b3fe472e074d03a5ec4e214c74af6668c8b17308cd5d892dab581cf095fd6.png | simple | <table><tr><td>Recipient</td><td>No. of embryos transferred</td><td>No. offetuses</td><td>Days of gestation</td><td>Fetal fibroblast cell lines</td><td>Mono-allelic cell lines (%)</td><td>Bi-allelic cell lines (%)</td></tr><tr><td>R725</td><td>205</td><td>6</td><td>26</td><td>F1, F2, F3, F4, F5, F6</td><td>F3, F4, F5(5... |
690318bff6b688d5493529c3366617f4d259312c08b03a490a30d4105f28f159.png | complex | <table><tr><td>Groups</td><td>Days</td><td>HOMA-IR</td><td>HOMA-β</td></tr><tr><td rowspan="3">NCD</td><td>0</td><td>4.18(3.66—5.16)<sup>bc</sup></td><td>200.98(143.36–346-67)<sup>bc</sup></td></tr><tr><td>28</td><td>4.23(3.71–4.77)<sup>bc</sup></td><td>192.12(186.6–265.41)<sup>bc</sup></td... |
65a44b40a95e922cb7de38d8d5818006c6e2de9d9a21ecb9571a651dbb2e35cd.png | simple | <table><tr><td>SVMs Models With Different Input Variable</td><td>Mean Absolute Percentage Error (MAPE) (%)</td></tr><tr><td>(a) Rebound Hammer (RH) Test</td><td>8.92%</td></tr><tr><td>(b) Ultrasonic Pulse Velocity (UPV) Test</td><td>9.25%</td></tr><tr><td>(c) SonReb (RH+UPV) Test</td><td>6.77%</td></tr></table> |
308a568c36e98408b978a6eae92632dcd852dccc19ed8c843204e2217d4f6885.png | simple | <table><tr><td>Province</td><td>Area (Hectares)</td><td>National Percentage</td><td>Province</td><td>Area (Hectares)</td><td>National Percentage</td></tr><tr><td>Agusan del Norte</td><td>244.98</td><td>0.1</td><td>Leyte</td><td>5,807.07</td><td>2.26</td></tr><tr><td>Aklan</td><td>1,144.44</td><td>0.45</td><td>Maguindan... |
2341023bb3d94eb5c48fabf811c9cb5d3e1b081dbcba448ce7e1041dbafca7fc.png | complex | <table><tr><td>Symptom</td><td>Appetite</td><td>Tired-ness</td><td>Depression</td><td>Well-being</td><td>Pain</td><td>Anxiety</td><td>Nausea</td><td>Short of Breath</td><td>Drowsiness</td></tr><tr><td></td><td colspan="9">One Month Before Death (n = 82)</td></tr><tr><td>Appetite</td><td>895.3</td><td></td><td></td><td>... |
6638f2fa650facf20ad4bd947f556c57c1c555b0fcb91ec4bd2da398ad3e1f5b.png | simple | <table><tr><td></td><td></td><td>Category</td><td></td><td></td><td></td><td></td><td>Category</td><td></td><td></td></tr><tr><td>Patient</td><td>1</td><td>2</td><td>3</td><td>4</td><td>Patient</td><td>1</td><td>2</td><td>3</td><td>4</td></tr><tr><td>1</td><td>1</td><td>0</td><td>0</td><td>0</td><td>24</td><td>0.14</td... |
8ddcc3872885acda5f6aeef76751430e4984080519a0b2893ed2649750add22e.png | complex | <table><tr><td rowspan="2">Cause of death</td><td colspan="2">Men</td><td colspan="2">Women</td></tr><tr><td>1997 (95% CI)</td><td>2014 (95% CI)</td><td>1997 (95% CI)</td><td>2014 (95% CI)</td></tr><tr><td>I00–I99 Diseases of the circulatory system</td><td>709.3 (699.9–718.6)</td><td>401.5 (395.2–407.... |
dc26ae1fbb8f0c77dc5c3ac6f7b407f6de2203379779632e28f7acb8cc1cb404.png | simple | <table><tr><td>Marker</td><td>D number</td><td>Primer sequences (5’>3’)</td><td>Annealing temperature (°C)</td><td>Product size (bp)</td></tr><tr><td>ATA29H01 </td><td>D12S1048</td><td>GGTCTGCTTAGGTCCCTTTT </td><td>55</td><td>209-229</td></tr><tr><td> </td><td> </td><td>AAGGAACCAAGGAGTGGAAG </td><td... |
adfc4752e768435adc0321ea19cfd6a973e625ef7b68f8b1e8302cc9c51d3137.png | simple | <table><tr><td>Gene</td><td>Forward</td><td>Reverse</td></tr><tr><td>EP1</td><td>5′-ATGGTGGGCCAGCTTGTC-3′</td><td>5′-GCCACCAACACCAGCATTG-3′</td></tr><tr><td>EP2</td><td>5′-TCCTTGCCTTTCACGATTT-3′</td><td>5′-AGAGCTTGGAGGTCCCATT-3′</td></tr><tr><td>EP3</td><td>5′-TGGTC... |
a0d9dd1bd04aafb3f534244687c82fc437c7bb62206ac2c69c8c50074b8911e8.png | complex | <table><tr><td rowspan="3"></td><td colspan="4">HIV-uninfected<sup>a</sup></td><td colspan="3">HIV-infected<sup>b</sup></td></tr><tr><td>All</td><td>Benin</td><td>Gabon</td><td>Mozambique</td><td>All</td><td>Kenya</td><td>Mozambique</td></tr><tr><td>n = 946</td><td>n = 349</td><td>n = 257</td><td>n = 340</td><td>n = 76... |
f877a26669b3fc5ffec99081e9a715ef527ca60647f80597719203699a27e273.png | complex | <table><tr><td rowspan="3">Body Areas</td><td colspan="6">Severity of Hirsutism</td><td rowspan="3"><i>p</i></td></tr><tr><td colspan="2">Mild</td><td colspan="2">Moderate</td><td colspan="2">Severe</td></tr><tr><td>Mean</td><td>SE *</td><td>Mean</td><td>SE</td><td>Mean</td><td>SE</td></tr><tr><td>Upper lip</td><td>1.9... |
0dc06eadc7ce4e20647bce2d7726e0b5bc3ceb9805143ee027081c74823df2f6.png | complex | <table><tr><td>Technique</td><td>Comments</td></tr><tr><td colspan="2">PRECONTRAST</td></tr><tr><td>Dark blood stacks typically in axial, coronal and sagittal planes e.g. HASTE</td><td>Provides vessel wall imaging as well as complementary information to CE-MRA regarding lumen</td></tr><tr><td>Noncontrast bright blood s... |
930c6741d6537af6153b99c60b1a85cc445d1a4ff72133c8959ce7c57e2f9cc1.png | simple | <table><tr><td>Gene symbol</td><td>Gene name</td><td>Log<sub>2</sub>FC (P/M)</td><td>FDR</td></tr><tr><td>Igj</td><td>Immunoglobulin joining chain</td><td>8.6779562</td><td>2.29E-11</td></tr><tr><td>Ly6c2</td><td>Lymphocyte antigen 6 complex, locus C2</td><td>12.30121239</td><td>2.92E-09</td></tr><tr><td>Slfn4</td><td>... |
da835a91fafb1974f8068a4146d6f5a96528773b66bbef70c67cf35807f66987.png | simple | <table><tr><td>Variable</td><td>Baseline</td><td>6 months</td></tr><tr><td>Energy (Kcal)</td><td>2225 ± 1109</td><td>1589 ± 384 **</td></tr><tr><td>Carbohydrate (g)</td><td>273 ± 194</td><td>199 ± 74 *</td></tr><tr><td>Protein (g)</td><td>98 ± 36</td><td>78 ± 23 *</td></tr><tr><td>Fat (g)<... |
a0ded3f2af5127bd996b7d6abda419dc72289f41d05390271d6499e1f4b606fd.png | simple | <table><tr><td></td><td>Knee pain<i>n </i>= 404</td><td>Symptomaticknee OA<i>n </i>= 109</td><td>OR (95% CI)</td></tr><tr><td>Pain unbearable at times</td><td>36%</td><td>59%</td><td>2.0 (1.3 to 3.3)</td></tr><tr><td>Limited activity</td><td>39%</td><td>64%</td><td>2.4 (1.5 to 4.0)</td></tr><tr><td>Herbal medicine</td>... |
227bbc83cf3746211a67b68be817d86b08d463ede9f786d54144076700949c23.png | complex | <table><tr><td colspan="7">S-RNase Region (codon positions)</td></tr><tr><td>Test</td><td>HVa (1-38)</td><td>HVb (44-62)</td><td>C3 (63-68)</td><td>V1 (69-84)</td><td>C4 (85-93)</td><td>V2 (94-131)</td></tr><tr><td>ωp/ωsα<i>Physalis </i>codons</td><td>7,8, 10,11, 13,14,15, 26, 33</td><td>44, 46, 4952, 53... |
d6b4d8751feb7a62f5a566b4769def58acf393b3e64b0fbcb28298c0a0123e93.png | complex | <table><tr><td>Species</td><td>Volume (μL)</td><td>Mycotoxin</td><td>Extraction Procedure</td><td>Detection Technique</td><td>LOD (μg/L)</td><td>LOQ (μg/L)</td><td>Reference</td></tr><tr><td colspan="8"><i>Single mycotoxin</i></td></tr><tr><td>Human</td><td>50</td><td>OTA</td><td>LLE: CH<sub>2</sub>Cl<su... |
a184f66ee31023854512c4f4c81f43e56c55c9e7a1a7b80b8d4c9243cf232136.png | simple | <table><tr><td>Product/active ingredient(s)</td><td>Formulation</td><td>Country of origin*</td><td>2005 availability (n = 29)</td><td>Named in the top 3 sellers in 2005 (n = 28)</td><td>Mean selling price 2005<sup>†</sup></td></tr><tr><td>1. artemether/lumefantrine</td><td>20/120 mg tablets, <i>co-formulated</i><... |
86443e811e0145c8b6511ad24d81220eec1087b3a92973e6073417cf237359f2.png | complex | <table><tr><td></td><td colspan="3">Overall survival</td><td colspan="3">Distant disease-free survival</td></tr><tr><td></td><td>HR</td><td>95% CI</td><td><i>P</i></td><td>HR</td><td>95% CI</td><td><i>P</i></td></tr><tr><td>pT2 + pT3</td><td>1.75</td><td>0.99 to 3.10</td><td>0.06</td><td>1.33</td><td>0.83 to 2.15</td><... |
90f87ed6a577c7a2903c828da6c831139ad45fcae06a8d5dba102619a3bbe356.png | simple | <table><tr><td>Reference strains</td><td>International code<sup>1</sup></td><td>Source</td></tr><tr><td><i>L</i>.(<i>L</i>.)<i>mexicana </i></td><td>MHOM/BZ/62/BEL21</td><td>1</td></tr><tr><td><i>L</i>.(<i>L</i>.)<i>mexicana </i></td><td>MHOM/BZ/62/M379</td><td>1</td></tr><tr><td><i>L</i>.(<i>L</i>.)<i>amazonensis </i>... |
ab06a966021fbe991c8c14e13469afa08f6b6c4190b7736daea7138c93183ed3.png | complex | <table><tr><td>IHC</td><td colspan="2">FISH</td></tr><tr><td> </td><td>Positive</td><td>Negative</td></tr><tr><td>Positive</td><td>9</td><td>5</td></tr><tr><td>Negative</td><td>2</td><td>6</td></tr><tr><td>P value</td><td>0.183</td><td> </td></tr></table> |
10ff450962b0330df253bff1d926143fae6bed1af0bc7c559258b7cfddb8de61.png | simple | <table><tr><td>Amplicon</td><td>Test of equality*</td><td>Test of variance**</td></tr><tr><td>Cav</td><td>p = 0.24</td><td>p < 0.001</td></tr><tr><td>CTGF</td><td>p < 0.001</td><td>p < 0.001</td></tr><tr><td>Eln</td><td>p = 1</td><td>p < 0.001</td></tr><tr><td>FN</td><td>p = 0.65</td><td>p < 0.001</td></... |
c93ef19ef8da8c1d2fbf437d7143ac0f53c96bdacda570e01bab1df071dfd6a3.png | simple | <table><tr><td>Scenarios (Detailed description in Method section)and total number of respondents</td><td><i>Expected responses (Detailed description in </i>Method<i> section)</i></td><td><i>Most often selected strategy by French respondents(N = 99)</i></td><td>Agreement in French study with expected choice(Yes/No/Parti... |
86104853957dcb90debbd5a16345fe229dabf4d2379efa6d605bafb63511ceae.png | complex | <table><tr><td>Genotype</td><td colspan="2">Number of subjects</td><td colspan="3">Overall effect</td><td colspan="3">Heterogeneity</td></tr><tr><td></td><td>COPD</td><td>Total</td><td>OR (95%CI)</td><td>Z</td><td>p</td><td>Chi<sup>2</sup></td><td>p</td><td>I<sup>2 </sup>(%)</td></tr><tr><td>GA/GG</td><td>1432/1201</td... |
cb39a28b12963463ce7cfdb79eabd2ab1982a5c1590c0ea844d313ff8afc6383.png | simple | <table><tr><td>Sample name</td><td>Total reads</td><td>Total mapped</td><td>Multiple mapped</td><td>Uniquely mapped</td></tr><tr><td>L1</td><td>51313614</td><td>37633474 (73.34 %)</td><td>1891840 (3.69 %)</td><td>35741634 (69.65 %)</td></tr><tr><td>L2</td><td>38408586</td><td>28132542 (73.25 %)</td><td>1626290 (4.24 %)... |
96f8875d467911661196450432415c82caf1b78ff44c87d70708cb6fbc06b815.png | complex | <table><tr><td></td><td colspan="2">Personality Disorder</td><td colspan="2">Healthy control</td></tr><tr><td></td><td>Passednumber, rate</td><td>Failednumber, rate</td><td><i>Passed</i><i>number, rate</i></td><td><i>Failed</i><i>number, rate</i></td></tr><tr><td>Hand lowering</td><td>55, 71.4%</td><td>22, 28.6%</td><t... |
75e2b1e699d93a136cbcba555a39da0a6dd72e11fc78c58a7207fbf6e99c01e4.png | simple | <table><tr><td>Gene name</td><td>Description</td><td>Adjusted <i>P</i> value (DB/WT)</td><td>Adjusted <i>P</i> value (GGQL/DB)</td></tr><tr><td>Pgam1</td><td>Phosphoglycerate mutase 1</td><td><0.0001</td><td>0.0038</td></tr><tr><td>Igf1</td><td>Insulin-like growth factor 1</td><td>0.0060</td><td>0.0029</td></tr><tr>... |
f77f91fb3423483dc45cd52b948182e23f9cf72c3159874da2462dc9452ec947.png | simple | <table><tr><td>Risk Factor Increase</td><td>Risk Factor</td><td>Mean % Change in Daily Visits per Risk Factor Increase</td><td>T-test p-value</td></tr><tr><td>0.01 ppm</td><td>Ozone</td><td>3.2 (1.4, 5)</td><td>0.000</td></tr><tr><td>1 μg m<sup>-3</sup></td><td>PM2.5</td><td>-0.2 (-0.6, 0.2)</td><td>0.331</td></tr... |
6213fe61e50c9d449c956aa8455e7af15492014904c332b5e038e657e7c0a423.png | complex | <table><tr><td>Knockout mouse</td><td>Phenotype</td><td>Reference</td></tr><tr><td rowspan="2">TRPC1</td><td>No effect on Ang II-induced cardiac hypertrophy</td><td rowspan="2">(39)</td></tr><tr><td>Reduced pathological cardiac hypertrophy by double knockout with TRPC4</td></tr><tr><td rowspan="2">TRPC3</td><td>Resista... |
dcbe0a72fb6d98870e2900aaf20bf0dc7a4448f9bae65433ee54b22eb913ecd5.png | simple | <table><tr><td>Category</td><td>Variables</td><td>Key references</td></tr><tr><td>Personal social learning indicators</td><td>Willingness to share ideas with other stakeholders</td><td>Pelling and High (2005); Collins and Ison (2009); Nilsson and Swartling (2009); Cundill (2010); Roux et al. (2011); Murray, Roux, and H... |
2c98d43ab0e084b7c6f3bdd39843ecdca776df0261aa318b91484859a15f4ce1.png | simple | <table><tr><td>Tissue</td><td>miRNA</td><td>Molecular targets</td><td>Functions</td><td>Reference</td></tr><tr><td>Aging heart</td><td>miR-21 ↑</td><td>ERK–MAP kinase signaling</td><td>Profibrotic [role on cardiac fibroblast (CFs)]</td><td>(51)</td></tr><tr><td>Aging heart</td><td>miR-22 ↑</td><td>Mim... |
4216056c5d1af6e0a647c8d359a2fb2ee36c923c6e10d1d5a59cfa457e27c1fe.png | complex | <table><tr><td></td><td colspan="6">Cisplatin excretion</td></tr><tr><td></td><td colspan="2">0–12 h</td><td colspan="2">12–24 h</td><td colspan="2">24–48 h</td></tr><tr><td></td><td>SCT (R/<i>p</i> value)</td><td>ULiR (<i>p</i> value)</td><td>SCT (R/<i>p</i> value)</td><td>ULiR (<i>p</i> value)</td><... |
634eb4c98902f0157fadaf5899518dcb568207cc6b13371d78c421171af4c047.png | complex | <table><tr><td rowspan="3">Type of TEAE observed</td><td colspan="4">No. (%) of subjects</td></tr><tr><td colspan="2">ESRD subjects (<i>n</i> = 8)</td><td rowspan="2">Healthy subjects (<i>n</i> = 8)</td><td rowspan="2">Total (<i>N</i> = 16)</td></tr><tr><td>Dosing after hemodialysis</td><td>Dosing before hemodialysis</... |
84a0df35d85cd0e263ae144ea3c33ab2517ae96f237a6b71320d68bb5b231fb9.png | complex | <table><tr><td colspan="2">Clinical N staging</td></tr><tr><td>cN0</td><td>3 (11.5%)</td></tr><tr><td>cN1</td><td>6 (23.1%)</td></tr><tr><td>cN2</td><td>14 (53.8%)</td></tr><tr><td>cN3</td><td>3 (11.5%)</td></tr></table> |
86121301a7a292f1a0fb3550553f33854ee8bea15120246272ff946cfa5ab49a.png | simple | <table><tr><td>Species (tax id, short name)</td><td>Number of proteins</td><td>Number of PPI</td><td>Source</td></tr><tr><td><i>E. coli</i> K12 (83333, eco)</td><td>4121</td><td>216426</td><td>SNDB [22]</td></tr><tr><td><i>S. typhimurium</i> (99287, stm)</td><td>4239</td><td>94609</td><td>SNDB [22]</td></tr><tr><td><i>... |
84b5bfd938f3a90c8ff6e9b5d3141760aa80f0ceb05ef7de0a0fb7d37643627c.png | simple | <table><tr><td>Noise</td><td>Cluster Number</td><td>GO MF (-log P-value)</td><td>GO BP (-log P-value)</td><td>GO CC (-log P-value)</td></tr><tr><td>0%</td><td>50</td><td>5.18</td><td>7.44</td><td>6.38</td></tr><tr><td>5%</td><td>44.15 ± 2.28</td><td>5.19 ± 0.19</td><td>7.34 ± 0.31</td><td>6.52 ± 0.3... |
55fb7c423c9d09851b8b2761beed2469e453c8a0bb38cd8b2fe5fc6bbafd878e.png | simple | <table><tr><td>Variables</td><td>Total (<i>n</i> = 223)</td><td>U (<i>n</i> = 99)</td><td>B (<i>n</i> = 37)</td><td>V (<i>n</i> = 30)</td><td>B + V (<i>n</i> = 57)</td></tr><tr><td>Anxious/depressed <i>n</i> (%)</td><td>16.0 (7.2)</td><td>4.0 (4.0)</td><td>3.0 (8.1)</td><td>4.0 (13.3)</td><td>5.0 (8.8)</td></tr><tr><td... |
bd6d9d3128175b649e02b2831c7ed0f777da2d5aba08f89be9818c398450c68f.png | complex | <table><tr><td colspan="2">Age (yr)*</td><td>37.14 ± 7.58</td></tr><tr><td colspan="2">Employment record (yr)*</td><td>11.48±4.47</td></tr><tr><td rowspan="3">Educational level**</td><td>Two trained courses after diploma</td><td>8(2.23)</td></tr><tr><td>Baccalaureate</td><td>311(86.11)</td></tr><tr><td>Master... |
a4c04f52cd9ea4f6a90d54c3a7e8671e7e79b51cd9ab9d4c131e018a24ffb402.png | complex | <table><tr><td rowspan="2">Land</td><td rowspan="2">SE index* <sup>a</sup></td><td colspan="3">NO<sub>2</sub></td><td rowspan="2">Education* <sup>b</sup></td><td colspan="3">NO<sub>2</sub></td></tr><tr><td>n</td><td>Mean</td><td>S. D.</td><td>n</td><td>Mean</td><td>S. D.</td></tr><tr><td rowspan="5">Urban <50%</td><... |
296447801ec1b121cc2d2b61456e0083e15e04bb3400ab72e0e9517a79eae53a.png | simple | <table><tr><td>Meta-Method</td><td>Mean Error</td></tr><tr><td>Fisher</td><td>0.276</td></tr><tr><td>POE with <i>Bss/Wss </i></td><td>0.375</td></tr><tr><td>POE with <i>IC </i></td><td>0.301</td></tr><tr><td>GeneMeta</td><td>0.525</td></tr><tr><td>RankProd</td><td>0.475</td></tr><tr><td>Simple</td><td>0.617</td></tr><t... |
285e4a0c9c0bae47de998878964cd767337374a5aa2223074335d54b2c403390.png | complex | <table><tr><td>Question</td><td>Level of ecological framework targeted</td></tr><tr><td colspan="2">Introduction</td></tr><tr><td>1. How long have you worked/lived in [name of agency or community]?</td><td>N/A</td></tr><tr><td colspan="2">Meaning of Good Health</td></tr><tr><td>First, I want you to think about your own... |
f6b99bfd90033c9b7a816569decdbdb08b0a4a56666a195130a0f92c3ae46ad6.png | complex | <table><tr><td>Drug</td><td>Cases (n=32)</td><td>Controls (n=64)</td><td>p</td></tr><tr><td colspan="4">Zidovudine</td></tr><tr><td>Yes</td><td>11</td><td>12</td><td>0.15</td></tr><tr><td>No</td><td>21</td><td>52</td><td> </td></tr><tr><td colspan="4">Lamivudine</td></tr><tr><td>Yes</td><td>17</td><td>28</td><td>0.5</t... |
0fbcca7e6e48de508b8c1f067ff9196d0711323e34dab8336b7637fd51576d50.png | complex | <table><tr><td>Characteristics</td><td>Frequency (%)</td><td>OR (95% CI)</td><td>p-value</td></tr><tr><td>Gender</td><td> </td><td> </td><td><0.001</td></tr><tr><td>Male</td><td>335 (65.4)</td><td>Reference</td><td rowspan="2"> </td></tr><tr><td>Female</td><td>503 (76.1)</td><td>1.90 (1.44-2.51)</td></tr><tr><td>Age... |
58a29756315fbc4554597cc45304ed519d33d1dbfb0b9a8e7e5ac8e7a695897c.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="3">Univariate</td><td colspan="3">Multivariate</td></tr><tr><td><i>P</i></td><td>HR</td><td>95% CI</td><td><i>P</i></td><td>HR</td><td>95% CI</td></tr><tr><td>Sex</td><td>0.880</td><td>1.021</td><td>0.778-1.339</td><td>0.266</td><td>1.176</td><td>0.883-1.566</td></tr... |
915beb632d0c2800020d6c6e7bd92c23a832811575052b51a64c34fa8827fd21.png | complex | <table><tr><td><i>Exposure to iAs in Water</i></td><td>N<sup>a</sup></td><td colspan="2">Range</td><td>AM</td><td>GM</td><td>GSD</td></tr><tr><td>iAs, current concentration (ppb)</td><td>258</td><td>3.1</td><td>215.2</td><td>42.9</td><td>24.4</td><td>2.9</td></tr><tr><td>iAs, cumulative exposure 1993-2008 (ppm.years)</... |
29adf2912bb570f0c8d6b4e5e4d0ca8a119dbdac2ff626710f0e04df5fbbd9e9.png | simple | <table><tr><td>Variable</td><td>Survivors (<i>n</i> = 36)</td><td>Nonsurvivors (<i>n</i> = 25)</td><td>P value</td></tr><tr><td>cTnT (pg/mL), median (IQL) </td><td>20 (18–24)</td><td>34.5 (27.5–41.5)</td><td><0.05*</td></tr></table> |
cbf255a42a56b8f19dc369f2edba6113298d5a0dc6c23b40d7f6b913dc7d4317.png | complex | <table><tr><td>Gene</td><td colspan="2">Positions and nt sequence sizes (bp)</td><td colspan="2">Start and stop codons</td><td colspan="2">tRNA Anti-codons</td><td colspan="2">Intergenic nt (bp)</td></tr><tr><td></td><td>PL (5’-3’)</td><td>PC (5’-3’)</td><td>PL</td><td>PC</td><td>PL</td><td>PC</... |
72bf72ed490d72b9ba0b75ca167e9ce0859020b1d6f8d69d275cfac491fe001f.png | complex | <table><tr><td>Materials employed</td><td>Composition</td><td>Manufacturer</td></tr><tr><td rowspan="2">GC Fuji II Universal Restorative</td><td>Powder: 95% fluoroaluminosilicate glass (amorphous)5% polyacrylic acid</td><td rowspan="2">G.C. Corporation, Tokyo, Japan </td></tr><tr><td>Liquid: 50% distilled water40% poly... |
42101e5986d4fa445bfac8a75cab577e832c703643371812bb4b44782d4a846f.png | simple | <table><tr><td>Data set</td><td>Number of instances</td><td>Number of attributes</td></tr><tr><td>Sonar</td><td>208</td><td>60</td></tr><tr><td>Live disorder</td><td>345</td><td>6</td></tr><tr><td>Breast cancer</td><td>680</td><td>10</td></tr><tr><td>Cystic fibrosis</td><td>177</td><td>Depends on q</td></tr><tr><td>Leu... |
cdf47841f2d916fb1e4ee0ff8b3fad3b82d3897cefdcf645f8851df59559f396.png | simple | <table><tr><td> </td><td>Group O (<i>n</i> = 40)</td><td>Group L (<i>n</i> = 39)</td><td><i>p</i> values<sup>a</sup></td></tr><tr><td>Surgical indication</td><td> </td><td> </td><td>0.968<sup>b</sup></td></tr><tr><td> Inflammation</td><td>3 (7.50)</td><td>3 (7.69)</td><td> </td></tr><tr><td> Stricture</td><td>24 (60.00... |
e0ca55f97f2c4d76cc367df20dbbe3b28fa131afde67ed36f0527441a76fa5bc.png | simple | <table><tr><td></td><td>No history of MTSS</td><td>History of MTSS</td><td>P-value</td><td>Effect size (r)</td></tr><tr><td>Navicular Drop (mm)</td><td>7.1 ± 2.0</td><td>7.1 ± 1.9</td><td>0.98</td><td>0.01</td></tr><tr><td>Leg Heel Alignment (°)</td><td>5.0 ± 1.4</td><td>5.1 ± 2.0</td><td>0.72<... |
f51fdfd6081615fbcc41d2b658c3bbc683b24b97256c765ddad786296650af8e.png | simple | <table><tr><td><underline>Sociodemographics</underline></td><td><underline>% of full sample</underline></td></tr><tr><td>Age (mean, SD)</td><td>32.6, 13.0</td></tr><tr><td>Minority/racial group member</td><td>50.2</td></tr><tr><td>Not married</td><td>45.0</td></tr><tr><td>No. children in household</td><td>49.6</td></tr... |
948fb813213a24dfdf1215e26e809378d76bdecca5582c2beb23d10528fbcba8.png | simple | <table><tr><td></td><td>GUH (N = 34)</td><td>WHC (N = 21)</td><td>Total (N = 55)</td></tr><tr><td>Age (N = 55)</td><td>M = 55.4 SD = 8.2</td><td>M = 53.7 SD = 6.7</td><td>M = 54.7 SD = 7.6</td></tr><tr><td>Race/Ethnicity #</td><td></td><td></td><td></td></tr><tr><td> White (N = 19)</td><td>50%</td><td>10.5%</td><td>35.... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.